Recent Progress in Vascular Tissue-Engineered Blood Vessels

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) is the leading cause of mortality in the U.S., incurring significant treatment costs.
• Autologous veins are currently used for vascular replacement, but limitations exist.
• Tissue-engineered blood vessels (TEBVs) are emerging as a viable alternative for CVD treatment.

Purpose of the Study:

• To review current cell sources for TEBV fabrication.
• To summarize methods employed in TEBV construction.
• To present recent advancements in TEBV research and clinical applications.

Main Methods:

• Review of scientific literature on TEBV cell sources and fabrication techniques.
• Analysis of recent research findings in TEBV development.
• Compilation of data from ongoing and completed TEBV clinical studies.

Main Results:

• Diverse cell sources, including stem cells and endothelial cells, are utilized for TEBV engineering.
• Various fabrication methods, such as scaffolds and bioreactors, are employed to create functional TEBVs.
• Significant progress has been observed in preclinical research and early-phase clinical trials for TEBVs.

Conclusions:

• TEBVs demonstrate potential as effective replacements for damaged or diseased blood vessels.
• Continued research and clinical evaluation are crucial for the widespread adoption of TEBVs.
• TEBV technology holds promise for improving outcomes in cardiovascular disease treatment.